Myocardial revascularization for unstable angina pectoris

G C Kaiser1, H V Schaff, T Killip

  • 1Department of Surgery, St. Louis University, Missouri.

Circulation
|June 1, 1989
PubMed

Insights

Coronary artery bypass grafting (CABG) for unstable angina pectoris shows similar outcomes to stable angina, but requires better preoperative management and myocardial preservation to reduce risks.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Vascular Surgery

Background:

  • Unstable angina pectoris presents a significant challenge in cardiac surgery.
  • Coronary artery bypass grafting (CABG) is a primary treatment modality.
  • Outcomes and risk factors require detailed analysis.

Purpose of the Study:

  • To evaluate the efficacy and safety of CABG in patients with unstable angina pectoris.
  • To identify risk factors associated with morbidity and mortality.
  • To compare outcomes with those of patients with chronic stable angina.

Main Methods:

  • Systematic review of 14 reports published between 1978 and 1988.
  • Inclusion of 6,136 patients undergoing CABG for unstable angina pectoris.
  • Analysis of operative mortality, perioperative myocardial infarction, and postoperative low cardiac output.

Main Results:

  • Mean operative mortality was 3.7%, perioperative myocardial infarction 9.9%, and low cardiac output 16%.
  • No distinct risk factors for morbidity or mortality were identified compared to chronic stable angina.
  • Outcomes including angina relief, survival, and late myocardial infarction were comparable to chronic stable angina.

Conclusions:

  • CABG offers comparable benefits for unstable angina to stable angina.
  • Subgroup analysis reveals varied prognoses within unstable angina.
  • Improved preoperative management and myocardial preservation are crucial for reducing CABG-related complications.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...